There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Day One Biopharmaceuticals (DAWN – Research ...
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Diaceutics (DIUXF – Research Report) and Inspire ...
What is the market expecting for the first half? The post Looking at BlueScope shares? Here's your half-year results preview ...
Stifel analysts increased their price target on Boston Scientific Corporation (NYSE:BSX) shares from $115.00 to $120.00, while reiterating a Buy rating for the medical device company. The adjustment ...